Differential Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Profiles After Allergic Reactions to Messenger RNA Coronavirus Disease 2019 Vaccine.

J Infect Dis · 2022 · PMC8992327 · PMID 35325158

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The mRNA vaccine–allergic individuals mounted significantly lower IgG 1 titers against full-length SARS-CoV-2 S antigen ( P = .04) with lower trends in IgG 1 against the RBD and NTD subdomains following vaccination that did not reach statistical significance ( Figure 1A ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.